Barclays Forecasts Strong Price Appreciation for Agilent Technologies (NYSE:A) Stock

Agilent Technologies (NYSE:A) had its price objective boosted by Barclays from $125.00 to $150.00 in a report released on Thursday morning,Benzinga reports. The brokerage currently has an equal weight rating on the medical research company’s stock.

Several other equities analysts also recently issued reports on A. Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. Evercore ISI cut their price target on shares of Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating for the company in a report on Thursday, August 28th. Robert W. Baird increased their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday, August 28th. Finally, Wells Fargo & Company increased their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, September 15th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $142.17.

Agilent Technologies Stock Performance

Shares of A stock opened at $138.66 on Thursday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a fifty day moving average price of $122.36 and a 200 day moving average price of $116.28. The company has a market cap of $39.31 billion, a P/E ratio of 32.55, a PEG ratio of 4.52 and a beta of 1.26. Agilent Technologies has a 12 month low of $96.43 and a 12 month high of $153.84.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company’s revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts predict that Agilent Technologies will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Institutional Trading of Agilent Technologies

Hedge funds have recently bought and sold shares of the company. Capital A Wealth Management LLC boosted its position in Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after acquiring an additional 212 shares during the last quarter. Whipplewood Advisors LLC boosted its position in Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock worth $29,000 after acquiring an additional 186 shares during the last quarter. Stone House Investment Management LLC acquired a new stake in Agilent Technologies during the first quarter worth approximately $30,000. Opal Wealth Advisors LLC acquired a new stake in Agilent Technologies during the first quarter worth approximately $31,000. Finally, Ransom Advisory Ltd acquired a new position in shares of Agilent Technologies in the 1st quarter valued at $32,000.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.